Iridian Asset Management LLC Immuneering Corp Transaction History
Iridian Asset Management LLC
- $239 Million
- Q3 2025
A detailed history of Iridian Asset Management LLC transactions in Immuneering Corp stock. As of the latest transaction made, Iridian Asset Management LLC holds 275,086 shares of IMRX stock, worth $1.59 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
275,086Holding current value
$1.59 Million% of portfolio
0.75%Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
43Shares Held
4.08MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$6.11 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0574KShares$3.32 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$3.08 Million0.0% of portfolio
-
Southport Management, L.L.C. Wilson, WY245KShares$1.42 Million4.03% of portfolio
-
Geode Capital Management, LLC Boston, MA230KShares$1.33 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $153M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...